Register entryShortage reported
ESTEVE PHARMACEUTICALS, S.A.
- Registered sites
- 0
- Drug products
- 7
- Live patents
- 5
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Alert
Products in shortage
1| Drug | Presentation | Availability |
|---|---|---|
| Streptozocin Powder, For Solution | Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) | Available |
Exclusivity
Patents
5Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | Feb 2030 |
| QUZYTTIR | CETIRIZINE HYDROCHLORIDE | Feb 2030 |
Catalogue
Marketed products
7Showing 7 of 7.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Lysodren | mitotane | TABLET | NDA |
| Metopirone | Metyrapone | CAPSULE, GELATIN COATED | NDA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| QUZYTTIR | Cetirizine Hydrochloride | INJECTION | NDA |
| Zanosar | Streptozocin | POWDER, FOR SOLUTION | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.